Additional file 2: Table S1. of Clinical characteristics and outcomes according to age in lenalidomide-treated patients with RBC transfusion-dependent lower-risk MDS and del(5q)
التفاصيل البيبلوغرافية
العنوان:
Additional file 2: Table S1. of Clinical characteristics and outcomes according to age in lenalidomide-treated patients with RBC transfusion-dependent lower-risk MDS and del(5q)
Cumulative rates of AML progression by age group in lenalidomide-treated patients. AML, acute myeloid leukemia; MDS, myelodysplastic syndromes. (DOCX 14Â kb)